This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Compliance Remove Pharmaceutical Industry Remove World Health Related Topics
FDA Governance Licensing Public Health COVID-19 Hospitals More Related Topics >
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – May

SQA

JULY 8, 2022

88, Microbial Data Deviation Investigations in the Pharmaceutical Industry, January 2022. World Health Organization (WHO). WHO Pharmaceuticals Newsletter, No. PDA Technical Report No. PDA Technical Report No. 88 presents a holistic approach for performing a microbiological investigation.

Pharmaceutical Industry 40
Pharmaceutical Industry FDA Hospitals World Health 40
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2024

SQA

FEBRUARY 26, 2024

After receiving complaints, ANVSA performed joint inspections with local health surveillance agencies. The reported irregularities and the manufacturing conditions of the products, that is, compliance with Good Manufacturing Practices, were verified on the spot.

FDA 52
FDA Compliance COVID-19 Public Health 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 50,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024